BIORESTORATIVE THERAPIES, INC.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Revenue | $81.0K | $36.4K | $628.9K | $416.0K | $1.7K | $15.6K | $0 |
| Cost of Revenue | — | $102 | $261.5K | $213.8K | $208 | $1.3K | $0 |
| Gross Profit | $81.0K | $36.3K | $367.4K | $202.2K | $1.5K | $14.3K | $0 |
| Gross Margin | 100.0% | 99.7% | 58.4% | 48.6% | 87.6% | 91.6% | — |
| Operating Expenses | |||||||
| Research & Development | $2.2M | $2.9M | $2.1M | $1.4M | $1.6M | $756.8K | $12.0K |
| SG&A Expense | $3.9M | $3.2M | $3.9M | $2.3M | $2.3M | $3.0M | $1.4M |
| Operating Income | $-8.4M | $-7.8M | $-7.2M | $-4.9M | $-4.8M | $-5.6M | $-3.6M |
| Operating Margin | -10,338.6% | -21,414.0% | -1,140.1% | -1,183.3% | -282,873.2% | -35,746.1% | — |
| Interest Expense | $208.0K | $9.7K | $263.6K | $285.3K | $371.3K | $591.8K | $260.0K |
| Pretax Income | $-9.4M | $-8.6M | $-7.9M | $-5.6M | $-5.8M | — | — |
| Income Tax Expense | — | — | $0 | $0 | $0 | — | — |
| Net Income | $-9.4M | $-8.6M | $-7.9M | $-5.6M | $-5.8M | $-6.5M | $-4.1M |
| Net Margin | -11,660.1% | -23,755.4% | -1,259.9% | -1,343.2% | -342,333.0% | -41,931.6% | — |
| EPS (Basic) | $-0.58 | $-0.70 | $-1.07 | $-1.46 | $-0.12 | $-0.16 | $0.00 |
| EPS (Diluted) | $-0.58 | $-0.70 | $-1.07 | $-1.46 | $-0.12 | $-0.16 | $0.00 |
| Shares Outstanding (Basic) | 18.3M | 14.1M | 9.9M | 5.1M | 57.2M | 44.7M | 1.82B |
| Shares Outstanding (Diluted) | 18.3M | 14.1M | 9.9M | 5.1M | 57.2M | 44.7M | 1.82B |
| Dividends Per Share | — | — | — | — | — | — | — |